Browse > Article

Effects of rhBMP-2 with various carriers on bone regeneration in rat calvarial defect  

Lee, Seo-Kyoung (Department of Periodontics, National Health Insurance Corporation Ilsan Hospital)
Kim, Ji-Sun (Department of Periodontics, National Health Insurance Corporation Ilsan Hospital)
Kang, Eun-Jung (Osstem Co.)
Eum, Tae-Kwan (Osstem Co.)
Kim, Chang-Sung (Department of Periodontology, Yonsei University College of Dentistry)
Cho, Kyoo-Sung (Department of Periodontology, Yonsei University College of Dentistry)
Chai, Jung-Kiu (Department of Periodontology, Yonsei University College of Dentistry)
Kim, Chong-Kwan (Department of Periodontology, Yonsei University College of Dentistry)
Choi, Seong-Ho (Department of Periodontology, Yonsei University College of Dentistry)
Publication Information
Journal of Periodontal and Implant Science / v.38, no.2, 2008 , pp. 125-134 More about this Journal
Abstract
Purpose: Bone morphogenetic protein (BMP) is a potent differentiating agent for cells of the osteoblastic lineage. It has been used in the oral cavity under a variety of indications and with different carriers. However, the optimal carrier for each indication is not known. This study evaluated the bone regenerative effect of rhBMP-2 delivered with different carrier systems. Materials and Methods: 8 mm critical-sized rat calvarial defects were used in 60 male Sprague-Dawley rats. The animals were divided into 6 groups containing 10 animals each. Two groups were controls that had no treatment and absorbable collagen membrane only. 4 groups were experimentals that contained rhBMP-2 only and applied with absorbable collagen sponge($Collatape^{(R)}$), $MBCP^{(R)}$, Bio-$Oss^{(R)}$ each. The histological and histometric parameters were used to evaluate the defects after 2- or 8-week healing period. The shape and total augmented area were stable in all groups over the healing time. Results: New bone formation was significantly greater in the rhBMP-2 with carrier group than control group. rhBMP-2/ACS was the highest in bone density but gained less new bone area than rhBMP-2/$MBCP^{(R)}$ and rhBMP-2/Bio-$Oss^{(R)}$. The bone density after 8 weeks was greater than that after 2 weeks in all groups. However, rhBMP-2 alone failed to show the statistically significant difference in new bone area and bone density compared to control group. Also $MBCP^{(R)}$ and Bio-$Oss^{(R)}$ particles remained after 8 weeks healing period. Conclusion: These results suggest that rhBMP-2 with carrier system is an excellent inductive agent for bone formation and we can use it as the predictable bone tissue engieering technique. Future study will likely focus on the kinetics of BMP release and development of carriers that is ideal for it.
Keywords
Bone regeneration; carrier; recombinant human bone morphogenetic protein-2; rat calvarial defect;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bosch C. Importance of the critical-size bone defect in testing bone-regenerating materials. J Craniofac Surg 1998;9:310-316   DOI   PUBMED   ScienceOn
2 Cordaro. Clinical results of alveolar ridge augmentation with mandibular block bone grafts in partially edentulous patients prior to implant placement. Clin Oral Implants Res 2002;13:103-111   DOI   ScienceOn
3 Goldbefg VM. Natural history of autografts and allografts. Clin Orhop 1987;225:7-16
4 Han DK, Kim CS, Cho KS et al. Effect of a Fibrin-fibronectin sealing system as a carrier for recombinant human bone morphogenetic protein-4 on bone formation in rat calvarial defects. J Periodontol 2005 Dec;76:2216-2222   DOI   ScienceOn
5 Hong SJ, Kim CK, Cho KS et al. The Effect of a Fibrin-Fibronectin/$\beta$-Tricalcium Phosphate/Recombinant Human Bone Morphogenetic Protein-2 System on Bone Formation in Rat Calvarial Defects. Biomaterials 2006;27:3810-3816   DOI   ScienceOn
6 Misch CE, Dietsh F. Bone-grafting materials in implant dentistry. Implant Dent 1993;2:158-167   DOI   PUBMED   ScienceOn
7 Urist MR. Bone formation by autoinduction. Science 1965;150:893-899   DOI   ScienceOn
8 Urist MR. A bovine low molecular weight bone morphogenetic protein (BMP) fraction. Clin Orthop 1982;162:219-232
9 Winn SR. Carrier systems for bone morphogenetic proteins. Clin Orhop 1999;367(suppl):95s-106s   DOI
10 Sampath TK, Maliakal JC, Hauschka PV. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992;267:20352-20362   PUBMED
11 Wikesjoo UM. Periodontal repair in dogs: Effect of BMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 1999;26:392-400   DOI   ScienceOn
12 Lee YM, Kim CS, Kim CK et al. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. J periodontol 2000;71:418-424   DOI   ScienceOn
13 Marden LJ. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats. J Biomed Mater Res 1994;28:1127-1138   DOI   ScienceOn
14 Mao T, Chung M, Ting B et al. An experimental study on rhBMP-2 composite bone substitute for repairing craniomaxillary bone defects. Clin J Dent Res 1998;1:21-25
15 Choi SH, Cho KS, Kim CK et al. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J Periodontol 2002;73:63-72   DOI   ScienceOn
16 Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein(BMP) in repair of skull defects. Ann Surg 1982;196:100-109   DOI   PUBMED   ScienceOn
17 Mallonig JT. Autogenous and allogenic bone grafts in peiodontal therapy. Crit Rev Oral Biol Med 1992;3:333-352   DOI   PUBMED
18 Okura K. Takake M, Isibu I et al. Healing of segmental bone defects in rats induced by a $\beta$ TCP-MCPM cement combine with rhBMP-2. J Biomed Mater Res 1999;44:168-175   DOI   ScienceOn
19 Ahn SH, Han SB, Cho KS et al. Effect of Recombinant Human Bone Morphogenetic Protein- 4 with Carriers in Rat Calvarial Defects. J Periodontol 2003;74:787-797   DOI   ScienceOn
20 Uludag H. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers; A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 2000;50:227-238   DOI   ScienceOn
21 Kim CS, Choi SH, Cho KS et al. The effect of recombinant human bone morphogenetic protein-4 on the osteoblastic differentiation of mouse calvarial cells affected by Porphyromonas gingivalis. J Periodontol 2002;73:1126-1132   DOI   ScienceOn
22 Yamaguchi A. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 1996;220:336-371
23 Sigurdsson TJ. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int J Perio Rest Dent 1996;16:524-537
24 Alam MI, Asahina I. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitute. J Biomed Mater Res 2001;54:129-138   DOI   ScienceOn
25 Alam MI, Asahina I. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 2001;22:1643-1651   DOI   ScienceOn
26 Boden SD. Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 1996;137:3401-3407   DOI   ScienceOn
27 Pang EK, Han SB, Cho KS et al. Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in rat calvarial defects. J Periodontol 2004;75:1364-1370   DOI   ScienceOn
28 Karring T, Lindhe J, Cortellini P. Regenerative periodontal therapy. Clin Perio Imp Dent 2002;599-602
29 Dragoo MR, Sullivan HC. A clinical and hitological evaluation of autogenous iliac bone trafts in humans. II External root resorption. J Periodontol 1973;44:614-625   DOI   PUBMED
30 Mizutani H, Urist MR. The nature of bone morphogenetic protein(BMP) fractions derived from bovine bone matrix gelatin. Clin Orhop 1982;171:213-223
31 Sandor G, Clockie C, Urist M et al. Successful mandibular reconstruction using a BMP bioimplant. J Craniofac Surg 2001;12(2):119-127   DOI
32 Jung UW, Choi SY, Cho KS et al. The Effect of varying the Particle Size of Beta Tricalcium Phosphate carrier of Recombinant Human Bone Morphogenetic Protein-4 on Bone Formation in Rat Calvarial Defects. J Periodontol 2006;77:765-772
33 Hyun SJ, Kim CK, Kim CS et al. The effect of recombinant human bone morphogenetic protein-2, 4 and 7 on bone formation in rat calvarial defects. J Periodontol 2005;76:1667-1674   DOI   ScienceOn
34 Schwartz-Arad D. Surgical success of intraoral autogenous block onlay bone grafting for alveolar ridge augmentation. Implant Dent 2005;14:131-138   DOI   ScienceOn
35 Hollinger JO, Slots J, Bell et al. Carriers for bone morphogenetic proteins. Biometerials 1996;17:187-194   DOI   ScienceOn
36 Kim CS, Kim CK, Cho KS et al. Ectopic bone formation associated with recombinant human bone morphogenetic protein-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2004;19:1-7